Yoav Gronovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoav Gronovich has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Adi Maisel-Lotan
Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
3 shared publicationsIzhak Tuchman
Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, Jerusalem, Israel
2 shared publicationsNirit Eizenman
From the Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, affiliated with the Faculty of Medicine, Hebrew University of Jerusalem
2 shared publicationsRami Binenboym
From the Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, affiliated with the Faculty of Medicine, Hebrew University of Jerusalem
2 shared publications- Adi Maisel Lotan
Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Shmuel Beit 12, Jerusalem, Israel
1 shared publication - Adi Maisel Lotan
Department of Plastic and Reconstructive Surgery, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel
1 shared publication
Latest Publications
- 4 November 2026
- Published by Wiley in Microsurgery
- Vol. 46 (8)
Postoperative Outcomes Following Autologous Breast Reconstruction in Patients Receiving Selective Estrogen Receptor Modulators and Aromatase Inhibitors: A Multicenter Propensity Score‐Matched Cohort Study
Background: The perioperative management of endocrine therapy remains controversial in patients undergoing autologous breast reconstruction. Because selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) differ in their mechanisms of action and adverse‐effect profiles, we evaluated their associations with postoperative outcomes separately in a large multicenter propensity score‐matched cohort. Methods: This retrospective TriNetX study included patients undergoing autologous breast reconstruction. Preoperative exposure was defined as a documented SERM or AI prescription within 3 months of reconstruction. Exposure cohorts were mutually exclusive, and controls excluded both endocrine therapy classes. Separate 1:1 propensity score matching incorporated demographic, comorbidity, oncologic, treatment, venous thromboembolism, and antithrombotic covariates. Outcomes were assessed within 90 days. Results: After matching, 1993 SERM‐exposed patients were compared with 1993 controls and 3167 AI‐exposed patients with 3167 controls. SERM exposure was not significantly associated with evaluable 90‐day outcomes, including coded postoperative debridement (3.01% vs. 2.56%; RR, 1.18; 95% CI, 0.81–1.73; p = 0.39). AI exposure was associated with increased coded postoperative debridement (4.45% vs. 3.38%; RR, 1.33; 95% CI, 1.03–1.72; p = 0.028), while other evaluable outcomes were not significantly different. AI exposure was also associated with greater debridement hazard (HR, 1.44; 95% CI, 1.12–1.87; p = 0.0049). Conclusions: Documented SERM exposure was not significantly associated with evaluable postoperative outcomes, whereas AI exposure was associated with increased coded postoperative debridement. Because debridement codes lack anatomical specificity, this finding is exploratory and does not establish flap‐specific compromise. These separate analyses do not establish differences between endocrine therapy classes or support recommendations regarding perioperative continuation or discontinuation.
- 4 November 2026
- Published by Wiley in Microsurgery
- Vol. 46 (8)
Postoperative Outcomes Following Autologous Breast Reconstruction in Patients Receiving Selective Estrogen Receptor Modulators and Aromatase Inhibitors: A Multicenter Propensity Score‐Matched Cohort Study
Background: The perioperative management of endocrine therapy remains controversial in patients undergoing autologous breast reconstruction. Because selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) differ in their mechanisms of action and adverse‐effect profiles, we evaluated their associations with postoperative outcomes separately in a large multicenter propensity score‐matched cohort. Methods: This retrospective TriNetX study included patients undergoing autologous breast reconstruction. Preoperative exposure was defined as a documented SERM or AI prescription within 3 months of reconstruction. Exposure cohorts were mutually exclusive, and controls excluded both endocrine therapy classes. Separate 1:1 propensity score matching incorporated demographic, comorbidity, oncologic, treatment, venous thromboembolism, and antithrombotic covariates. Outcomes were assessed within 90 days. Results: After matching, 1993 SERM‐exposed patients were compared with 1993 controls and 3167 AI‐exposed patients with 3167 controls. SERM exposure was not significantly associated with evaluable 90‐day outcomes, including coded postoperative debridement (3.01% vs. 2.56%; RR, 1.18; 95% CI, 0.81–1.73; p = 0.39). AI exposure was associated with increased coded postoperative debridement (4.45% vs. 3.38%; RR, 1.33; 95% CI, 1.03–1.72; p = 0.028), while other evaluable outcomes were not significantly different. AI exposure was also associated with greater debridement hazard (HR, 1.44; 95% CI, 1.12–1.87; p = 0.0049). Conclusions: Documented SERM exposure was not significantly associated with evaluable postoperative outcomes, whereas AI exposure was associated with increased coded postoperative debridement. Because debridement codes lack anatomical specificity, this finding is exploratory and does not establish flap‐specific compromise. These separate analyses do not establish differences between endocrine therapy classes or support recommendations regarding perioperative continuation or discontinuation.
- Open Access
- 28 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7148
Pilot Study for Isolation of Stromal Vascular Fraction with Collagenase Using an Automated Processing System
There are many potential therapeutic applications for autologous adipose-derived stromal cells. These cells are found in a heterogeneous population isolated from adipose tissue called the stromal vascular fraction (SVF). Closed automated systems are available to release cells from the adherent stroma. Here, we test one system to evaluate the heterogeneous output for yield, purity, cellular characterization, and stemness criteria. The SVF was isolated from three donors using the Automated Cell Station (ACS) from BSL Co., Ltd., Busan, Republic of Korea. The SVF cellular output was characterized for cell yield and viability, immunophenotyping analysis, pluripotent differentiation potential, adhesion to plastic, and colony-forming units. Additionally, the SVF was tested for endotoxin and collagenase residuals. The SVF yield from the ACS system was an average volume of 7.9 ± 0.5 mL containing an average of 19 × 106 nucleated cells with 85 ± 12% viability. Flow cytometry identified a variety of cells, including ASCs (23%), macrophages (24%), endothelial cells (5%), pericytes (4%), and transitional cells (0.5%). The final concentrated product contained cells capable of differentiating into adipogenic, chondrogenic, and osteogenic phenotypes. Furthermore, tests for SVF sterility and purity showed no evidence of endotoxin or collagenase residuals. The ACS system can efficiently process cells from adipose tissue within the timeframe of a single surgical procedure. The cellular characterization indicated that this system can yield a sterile and concentrated SVF output, providing a valuable source of ASCs within the heterogeneous cell population.
- 28 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7148
Open AccessPilot Study for Isolation of Stromal Vascular Fraction with Collagenase Using an Automated Processing System
There are many potential therapeutic applications for autologous adipose-derived stromal cells. These cells are found in a heterogeneous population isolated from adipose tissue called the stromal vascular fraction (SVF). Closed automated systems are available to release cells from the adherent stroma. Here, we test one system to evaluate the heterogeneous output for yield, purity, cellular characterization, and stemness criteria. The SVF was isolated from three donors using the Automated Cell Station (ACS) from BSL Co., Ltd., Busan, Republic of Korea. The SVF cellular output was characterized for cell yield and viability, immunophenotyping analysis, pluripotent differentiation potential, adhesion to plastic, and colony-forming units. Additionally, the SVF was tested for endotoxin and collagenase residuals. The SVF yield from the ACS system was an average volume of 7.9 ± 0.5 mL containing an average of 19 × 106 nucleated cells with 85 ± 12% viability. Flow cytometry identified a variety of cells, including ASCs (23%), macrophages (24%), endothelial cells (5%), pericytes (4%), and transitional cells (0.5%). The final concentrated product contained cells capable of differentiating into adipogenic, chondrogenic, and osteogenic phenotypes. Furthermore, tests for SVF sterility and purity showed no evidence of endotoxin or collagenase residuals. The ACS system can efficiently process cells from adipose tissue within the timeframe of a single surgical procedure. The cellular characterization indicated that this system can yield a sterile and concentrated SVF output, providing a valuable source of ASCs within the heterogeneous cell population.
- Open Access
- 18 June 2024
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 56 (6) , 592-596
Evaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation
Background: Skin rejuvenation is a widely sought‐after goal, prompting advancements in laser technology for noninvasive and effective treatments. Ablative lasers, in particular, have evolved to address diverse skin concerns, with fractional ablative lasers offering better‐tolerated outcomes. The introduction of a novel ablative Thulium pulsed laser, based on Thulium‐doped Yttrium aluminum Perovskite (Tm:YAP) crystal, delivers precise and controlled skin rejuvenation by allowing customization of ablative microcolumns.Methods: A pilot in vivo study was conducted on the abdominal skin of a live female pig. Using the Laser Team Medical (LTM) prototype laser, treatments were administered with varying coagulation settings (minimal and maximum) and energies (32, 80, 120, and 160 mJ per microcolumn). Biopsies were harvested, fixed, and stained for subsequent analysis. The penetration depth and width of the microcolumns were evaluated.Results: Low coagulation settings produced ablative microcolumns with thermal affected zones of 160 µm width, while high coagulation settings resulted in wider zones of 400–530 µm. The ablation cavities' width was estimated to be less than 100 µm in both settings. The novel 1940 nm pulsed laser demonstrated superior microcolumn properties, offering potential advantages such as shorter downtime and increased efficacy compared to existing fractional ablative lasers.Conclusion: This study presents encouraging preliminary results regarding the efficacy and safety of the first ablative 1940 nm pulsed laser. The results show ablative microcolumns thinner than the counterpart devices, showing the device safety and potential higher efficacy along with short downtime. The LTM novel ablative 1940 nm pulsed laser holds immense potential for enhancing skin rejuvenation treatments due to its superior microcolumns properties. The versatility of this laser can open new treatment procedures and may extend to different areas of dermatology.
- 18 June 2024
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 56 (6) , 592-596
Open AccessEvaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation
Background: Skin rejuvenation is a widely sought‐after goal, prompting advancements in laser technology for noninvasive and effective treatments. Ablative lasers, in particular, have evolved to address diverse skin concerns, with fractional ablative lasers offering better‐tolerated outcomes. The introduction of a novel ablative Thulium pulsed laser, based on Thulium‐doped Yttrium aluminum Perovskite (Tm:YAP) crystal, delivers precise and controlled skin rejuvenation by allowing customization of ablative microcolumns.Methods: A pilot in vivo study was conducted on the abdominal skin of a live female pig. Using the Laser Team Medical (LTM) prototype laser, treatments were administered with varying coagulation settings (minimal and maximum) and energies (32, 80, 120, and 160 mJ per microcolumn). Biopsies were harvested, fixed, and stained for subsequent analysis. The penetration depth and width of the microcolumns were evaluated.Results: Low coagulation settings produced ablative microcolumns with thermal affected zones of 160 µm width, while high coagulation settings resulted in wider zones of 400–530 µm. The ablation cavities' width was estimated to be less than 100 µm in both settings. The novel 1940 nm pulsed laser demonstrated superior microcolumn properties, offering potential advantages such as shorter downtime and increased efficacy compared to existing fractional ablative lasers.Conclusion: This study presents encouraging preliminary results regarding the efficacy and safety of the first ablative 1940 nm pulsed laser. The results show ablative microcolumns thinner than the counterpart devices, showing the device safety and potential higher efficacy along with short downtime. The LTM novel ablative 1940 nm pulsed laser holds immense potential for enhancing skin rejuvenation treatments due to its superior microcolumns properties. The versatility of this laser can open new treatment procedures and may extend to different areas of dermatology.
- Open Access
- 8 May 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (23) , 4916-4921
Autologous Fat Breast Reconstruction with Implant Completion-Experience with 29 Consecutive Cases and 33 Breasts
Background: Implant-based breast reconstruction is the most prevalent form of breast reconstruction. Autologous fat grafting (AFG) was conceptualized as an alternative to implant-based breast reconstruction and was found to be a reliable reconstruction modality. However, usually, a few grafting rounds are required to create the desired shape and size of the breast. Current literature describes ample experience with AFG as an adjunct to implant-based breast reconstruction for improving appearance. However, the utilization of breast implants following initial AFG has been sparingly described. The primary advantage of this study is the creation of new fat tissue as a breast mound. The reconstruction is then concluded by inserting an implant into this new mound. This approach reduces the overall number of fat injections needed to achieve the desired outcome, as well as the total volume of the implant. Methods: This IRB-approved retrospective study was conducted between January 2015 and December 2021. All women who underwent delayed breast reconstruction with AFG during this timeframe and wanted to complete it with a silicone implant as a last stage were included in the study. Results: A total of 29 patients (33 breasts) underwent delayed breast reconstruction with AFG and a silicone implant as the final stage. In all cases, the results were satisfying without any major complications. Minor complications were observed with one patient and included an infection. Conclusions: The findings of this study have demonstrated the effectiveness of this procedure together with patient satisfaction, thus highlighting the potential advantages that this approach offers. Level of Evidence III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 8 May 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (23) , 4916-4921
Open AccessAutologous Fat Breast Reconstruction with Implant Completion-Experience with 29 Consecutive Cases and 33 Breasts
Background: Implant-based breast reconstruction is the most prevalent form of breast reconstruction. Autologous fat grafting (AFG) was conceptualized as an alternative to implant-based breast reconstruction and was found to be a reliable reconstruction modality. However, usually, a few grafting rounds are required to create the desired shape and size of the breast. Current literature describes ample experience with AFG as an adjunct to implant-based breast reconstruction for improving appearance. However, the utilization of breast implants following initial AFG has been sparingly described. The primary advantage of this study is the creation of new fat tissue as a breast mound. The reconstruction is then concluded by inserting an implant into this new mound. This approach reduces the overall number of fat injections needed to achieve the desired outcome, as well as the total volume of the implant. Methods: This IRB-approved retrospective study was conducted between January 2015 and December 2021. All women who underwent delayed breast reconstruction with AFG during this timeframe and wanted to complete it with a silicone implant as a last stage were included in the study. Results: A total of 29 patients (33 breasts) underwent delayed breast reconstruction with AFG and a silicone implant as the final stage. In all cases, the results were satisfying without any major complications. Minor complications were observed with one patient and included an infection. Conclusions: The findings of this study have demonstrated the effectiveness of this procedure together with patient satisfaction, thus highlighting the potential advantages that this approach offers. Level of Evidence III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 30 April 2024
- Published by Korean Society of Pediatric Emergency Medicine in Pediatric Emergency Medicine Journal
- Vol. 11 (2) , 65-70
Cosmetic outcomes of simple facial laceration suturing in the pediatric emergency department
Purpose: The long-term cosmetic outcomes of simple facial lacerations have not been well addressed, specifically regarding those of suturing by pediatric emergency physicians (PEPs) and plastic surgery (PS) residents. Methods: A retrospective study was performed at the pediatric emergency department of Shaare Zedek Medical Center in Jerusalem, Israel. Cosmetic outcomes of simple facial lacerations sutured within 1 year of the study were reviewed using digital photographs taken by legal guardians of children sutured in the department. The photographs were reviewed and rated blindly using the Stony Brook scar score as measures of cosmetic outcomes by 2 plastic surgeons and 1 PEP, as well as the general numeric score (GNS) rated by the guardians and the 3 doctors. The scores were compared between children sutured by PEPs (PEP group) and those sutured by PS residents (PS group). A sample size of 50 children in each study group was calculated to have enough power to show a difference. Results: Among a total of 108 children who participated in the study (median age, 4.0 years [interquartile range, 3.0-7.0]), 57 and 51 were sutured by PEPs and PS residents, respectively. Guardian-rated median GNS showed no difference between the 2 groups (PEP, 90.0 [70.0-95.0] vs. PS, 90.0 [60.0-90.0]; P = 0.310). In contrast, doctor-rated median GNS was higher in the PEP group (PEP, 75.0 [63.3-86.7] vs. PS, 70.0 [53.3-83.3]); P = 0.046). A Stony Brook scar score of 3 or higher was similarly frequent in both groups (PEP, 87.7% vs. PS, 74.5%; P = 0.173) with a low interrater agreement (Kappa = 0.36). Conclusion: Cosmetic outcomes of simple facial lacerations in the pediatric emergency department were favorable regardless of the specialty or expertise of doctors. The guardians were more satisfied with the outcomes, compared to the doctors.
- 30 April 2024
- Published by Korean Society of Pediatric Emergency Medicine in Pediatric Emergency Medicine Journal
- Vol. 11 (2) , 65-70
Open AccessCosmetic outcomes of simple facial laceration suturing in the pediatric emergency department
Purpose: The long-term cosmetic outcomes of simple facial lacerations have not been well addressed, specifically regarding those of suturing by pediatric emergency physicians (PEPs) and plastic surgery (PS) residents. Methods: A retrospective study was performed at the pediatric emergency department of Shaare Zedek Medical Center in Jerusalem, Israel. Cosmetic outcomes of simple facial lacerations sutured within 1 year of the study were reviewed using digital photographs taken by legal guardians of children sutured in the department. The photographs were reviewed and rated blindly using the Stony Brook scar score as measures of cosmetic outcomes by 2 plastic surgeons and 1 PEP, as well as the general numeric score (GNS) rated by the guardians and the 3 doctors. The scores were compared between children sutured by PEPs (PEP group) and those sutured by PS residents (PS group). A sample size of 50 children in each study group was calculated to have enough power to show a difference. Results: Among a total of 108 children who participated in the study (median age, 4.0 years [interquartile range, 3.0-7.0]), 57 and 51 were sutured by PEPs and PS residents, respectively. Guardian-rated median GNS showed no difference between the 2 groups (PEP, 90.0 [70.0-95.0] vs. PS, 90.0 [60.0-90.0]; P = 0.310). In contrast, doctor-rated median GNS was higher in the PEP group (PEP, 75.0 [63.3-86.7] vs. PS, 70.0 [53.3-83.3]); P = 0.046). A Stony Brook scar score of 3 or higher was similarly frequent in both groups (PEP, 87.7% vs. PS, 74.5%; P = 0.173) with a low interrater agreement (Kappa = 0.36). Conclusion: Cosmetic outcomes of simple facial lacerations in the pediatric emergency department were favorable regardless of the specialty or expertise of doctors. The guardians were more satisfied with the outcomes, compared to the doctors.
- 1 June 2023
- Published by Springer Nature
- p. 235-250
Planning Pre-pectoral Implant-Based Breast Reconstruction When Confronted with XRT
- 1 June 2023
- Published by Springer Nature
- p. 235-250
Planning Pre-pectoral Implant-Based Breast Reconstruction When Confronted with XRT
- 4 April 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 152 (6) , 1186-1189
An Innovative Surgical Device for Removal of Breast Implants
Summary: The use of breast implants is consistently on the rise owing to increases in aesthetic and reconstructive breast surgery. Implant rupture is a potential complication, the rate of which has increased over time. Therefore, implant removal or replacement is a common procedure, and needed for most breast implants at some point during the patient’s lifetime. Surgical removal of ruptured implants is messy, cumbersome, time-consuming, and, overall, unpleasant. The authors have developed a custom-made device that effectively removes a silicone implant, whether ruptured or intact. To determine its efficiency, the authors conducted a prospective clinical trial of 25 women (45 breasts) undergoing removal or replacement of breast implants with the device between January of 2019 and January of 2022. Device safety and efficiency were assessed, and the need for the device was evaluated through a survey among 25 board-certified plastic surgeons. The mean implant age was 12.8 years, and mean volume was 370 g. The mean time to extract the implant with the device was 10.7 seconds. Twenty-two implants (49%) were ruptured. There were no minor or major complications during the procedure or follow-up. The mean follow-up period was 6 months. Surgeons’ intention to use this device in their own practices for removal of intact and ruptured implants was very high. This novel device may prove indispensable for explantation of both intact and ruptured silicone implants. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
- 4 April 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 152 (6) , 1186-1189
An Innovative Surgical Device for Removal of Breast Implants
Summary: The use of breast implants is consistently on the rise owing to increases in aesthetic and reconstructive breast surgery. Implant rupture is a potential complication, the rate of which has increased over time. Therefore, implant removal or replacement is a common procedure, and needed for most breast implants at some point during the patient’s lifetime. Surgical removal of ruptured implants is messy, cumbersome, time-consuming, and, overall, unpleasant. The authors have developed a custom-made device that effectively removes a silicone implant, whether ruptured or intact. To determine its efficiency, the authors conducted a prospective clinical trial of 25 women (45 breasts) undergoing removal or replacement of breast implants with the device between January of 2019 and January of 2022. Device safety and efficiency were assessed, and the need for the device was evaluated through a survey among 25 board-certified plastic surgeons. The mean implant age was 12.8 years, and mean volume was 370 g. The mean time to extract the implant with the device was 10.7 seconds. Twenty-two implants (49%) were ruptured. There were no minor or major complications during the procedure or follow-up. The mean follow-up period was 6 months. Surgeons’ intention to use this device in their own practices for removal of intact and ruptured implants was very high. This novel device may prove indispensable for explantation of both intact and ruptured silicone implants. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
- 23 February 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 149 (3) , 386e-391e
Hybrid Prepectoral Direct-to-Implant and Autologous Fat Graft Simultaneously in Immediate Breast Reconstruction: A Single Surgeon’s Experience with 25 Breasts in 15 Consecutive Cases
Background: The direct-to-implant method depends on the quality of the mastectomy flaps and can be used only when the flaps are adequately perfused. Even though the method was designed to be a definitive reconstruction procedure, it has been associated with an increased likelihood that additional operative revision will be required in order to achieve the expected final cosmetic outcome. The authors describe a hybrid prepectoral direct-to-implant method that combines autologous fat grafting in the superior medial pole with immediate reconstruction. Methods: In this prospective study, 15 patients (25 reconstructed breasts) underwent simultaneous hybrid prepectoral direct-to-implant reconstruction together with autologous fat grafting performed by a single senior plastic surgeon (Y.G). Results: The mean quantity of autologous fat grafted in the superior medial aspect of the breast was 59.4 ± 12.8 cc. The mean total volume of the hybrid reconstructed breast, including implant and autologous fat graft, was 497.2 ± 89.1 cc. Satisfying final outcomes were achieved in all cases. There were no major complications, although minor complications were observed. Conclusions: The authors’ hybrid approach allows the surgeon to achieve a more satisfying outcome with regard to the cleavage area. It results in a better natural appearance, an improved contour, and reduced upper pole rippling and deflation, with a lower likelihood that an additional operative revision will be required to achieve the desired final aesthetic outcome. The authors believe that their hybrid approach should be implemented as an integral part of the direct-to-implant prepectoral reconstruction procedure. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
- 23 February 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 149 (3) , 386e-391e
Hybrid Prepectoral Direct-to-Implant and Autologous Fat Graft Simultaneously in Immediate Breast Reconstruction: A Single Surgeon’s Experience with 25 Breasts in 15 Consecutive Cases
Background: The direct-to-implant method depends on the quality of the mastectomy flaps and can be used only when the flaps are adequately perfused. Even though the method was designed to be a definitive reconstruction procedure, it has been associated with an increased likelihood that additional operative revision will be required in order to achieve the expected final cosmetic outcome. The authors describe a hybrid prepectoral direct-to-implant method that combines autologous fat grafting in the superior medial pole with immediate reconstruction. Methods: In this prospective study, 15 patients (25 reconstructed breasts) underwent simultaneous hybrid prepectoral direct-to-implant reconstruction together with autologous fat grafting performed by a single senior plastic surgeon (Y.G). Results: The mean quantity of autologous fat grafted in the superior medial aspect of the breast was 59.4 ± 12.8 cc. The mean total volume of the hybrid reconstructed breast, including implant and autologous fat graft, was 497.2 ± 89.1 cc. Satisfying final outcomes were achieved in all cases. There were no major complications, although minor complications were observed. Conclusions: The authors’ hybrid approach allows the surgeon to achieve a more satisfying outcome with regard to the cleavage area. It results in a better natural appearance, an improved contour, and reduced upper pole rippling and deflation, with a lower likelihood that an additional operative revision will be required to achieve the desired final aesthetic outcome. The authors believe that their hybrid approach should be implemented as an integral part of the direct-to-implant prepectoral reconstruction procedure. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
- 27 November 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (S3) , 633-640
Comparison Between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction: a Case Series Analysis
- 27 November 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (S3) , 633-640
Comparison Between Prepectoral and Subpectoral Direct-to-Implant Breast Reconstruction: a Case Series Analysis
- 1 June 2018
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 141 (6) , 1386-1391
Innovative Surgical Approach Using a Mesh Sling for the Aging Neck
Rejuvenation of the neck is essential to achieve a young facade. Different approaches for aging neck rejuvenation have been developed throughout the years. Most of them focus on specific elements that contribute to the aging neck. The main drawbacks of these techniques are recurrence of the platysma bands, malposition, deformations, salivary problems, and defatting. These disadvantages and limitations have led the author to create a novel surgical approach to improve the aging neck that would be suitable for most patients. Instead of dealing with each of the elements of the aging neck, the author’s approach involves use of a sling to elevate all the descending elements as a whole to create a natural and longstanding result. Since March of 2014, 10 patients have been operated on for neck lifting with this new approach. Four different types of material have been used: absorbable synthetic braided (Vicryl) in five patients, semiabsorbable synthetic braided and monofilament (Vypro) in one patient, absorbable synthetic matrix (TIGR) in three patients, and biological mesh–allograft material (AlloDerm) in one patient. Follow-up visits were made after 10 days, 3 months, 6 months, and annually. In all cases, the operations were uneventful. There were no major complications. Minor complication occurred in one patient with the Vypro mesh. The mesh caused stiffness and was replaced. Final aesthetic results were satisfactory in all cases. Current approaches for improvement of the aging neck do not fit all aging neck cases and are suitable for only a specific dominant element. The aging neck tends to reappear faster than expected because of recurrence or dominance of another element. The author’s novel approach is more predictable and is suitable for most cases regardless of the dominant part causing the aging. More experience and longer follow-up are needed to choose the most appropriate material for the mesh. Therapeutic, IV.
- 1 June 2018
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 141 (6) , 1386-1391
Innovative Surgical Approach Using a Mesh Sling for the Aging Neck
Rejuvenation of the neck is essential to achieve a young facade. Different approaches for aging neck rejuvenation have been developed throughout the years. Most of them focus on specific elements that contribute to the aging neck. The main drawbacks of these techniques are recurrence of the platysma bands, malposition, deformations, salivary problems, and defatting. These disadvantages and limitations have led the author to create a novel surgical approach to improve the aging neck that would be suitable for most patients. Instead of dealing with each of the elements of the aging neck, the author’s approach involves use of a sling to elevate all the descending elements as a whole to create a natural and longstanding result. Since March of 2014, 10 patients have been operated on for neck lifting with this new approach. Four different types of material have been used: absorbable synthetic braided (Vicryl) in five patients, semiabsorbable synthetic braided and monofilament (Vypro) in one patient, absorbable synthetic matrix (TIGR) in three patients, and biological mesh–allograft material (AlloDerm) in one patient. Follow-up visits were made after 10 days, 3 months, 6 months, and annually. In all cases, the operations were uneventful. There were no major complications. Minor complication occurred in one patient with the Vypro mesh. The mesh caused stiffness and was replaced. Final aesthetic results were satisfactory in all cases. Current approaches for improvement of the aging neck do not fit all aging neck cases and are suitable for only a specific dominant element. The aging neck tends to reappear faster than expected because of recurrence or dominance of another element. The author’s novel approach is more predictable and is suitable for most cases regardless of the dominant part causing the aging. More experience and longer follow-up are needed to choose the most appropriate material for the mesh. Therapeutic, IV.